Akari Therapeutics PLC (AKTX)

[nicho144]

Day 2 short ville.

www.fusz.yolasite.com

has cash problems
needs partners
drug may have unaddressed side effects as inferred from their disclaimer
oversold and ready for shorts to pile in and myself EOD 4 and tomorrow 2.8
fundamentals are negative and their is no real product..

product has limited marketing value given rarity of disease and questions remain whether the drug is signficantly better than the placebo. and whether the death of a person involved in the study could have been affected by the drug is not fully explored in my opinion. its 67% success rate needs to be qualified against the backdrop of ineffective treatments..for example a simple discontinuation of the previous treatment under placebo would that beat their 67% figure... probably since they did not relay the actual figures to properly quantify and clarify whether this could be the case.

the price only up so much because of well timed news and low float enthusiasts and pumpers. be warned professionals have to now clean up the party.